|
|
Product Description
With each day that passes, every hour, every moment, loss threatens our sense of security and immortality. Dori Bohntinsky, a Speech/Language Pathologist seasoned with health care experience, shares her recovery from the tragedy of loss when her fourteen-year old daughter, Cj, suddenly developed a rare form of leukemia. The Healing Room is an odyssey in discovering joy and inspiration during an eighteen-month journey through loss—the four-month illness and death of Cj, the death of Dori’s mother, and the death of Dori’s father…. More >>
Product Description
This digital document is a journal article from Comparative Biochemistry and Physiology, Part C, published by Elsevier in . The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.
Description:
The sea squirt Halocynthia roretzi metabolizes fucoxanthin, and subsequently accumulates its derived carotenoids with characteristic structures. In the present study, we isolated halocynthiaxanthin and fucoxanthinol as carotenoids having antiproliferative activity from H. roretzi. Halocynthiaxanthin and fucoxanthinol inhibited the growth of HL-60 human leukemia cells in a dose- and time-dependent… More >>
Product Description
This completely revised and enlarged 3rd edition continues the idea of the previous version to provide an up-to-date overview of blood and marrow transplantations. Indication to transplantation and pre-transplant considerations are discussed in detail before the transplant procedure with all acute and delayed procedure is described. An outlook on the latest developments and their future aspects is included, and problems and pre- and post-transplant complications are discussed. This book helps practising hematologists, oncologists,and other physicians as well as physicians in training and students to develop an idea as to when blood and marrow transplantation should be considered, what the costs are and how a do… More >>
Product Description
This new book brings together leading research from around the globe. Leukaemia is cancer that begins in blood cells. In people with leukaemia, the bone marrow produces abnormal white blood cells. The abnormal cells are leukaemia cells. At first, leukaemia cells function almost normally. In time, they may crowd out normal white blood cells, red blood cells, and platelets. The scope of the book includes the four common types of leukaemia: chronic lymphocytic leukaemia (chronic lymphoblastic leukaemia, CLL) – most often affecting people over age 55; chronic myeloid leukaemia (chronic myelogenous leukaemia, CML) – affects mainly adults; acute lymphocytic leukaemia (acute lymphoblastic leukaemia, ALL) – the most co… More >>
Product Description
This new book brings together leading research from around the globe. Leukaemia is cancer that begins in blood cells. In people with leukaemia, the bone marrow produces abnormal white blood cells. The abnormal cells are leukaemia cells. At first, leukaemia cells function almost normally. In time, they may crowd out normal white blood cells, red blood cells, and platelets. The scope of the book includes the four common types of leukaemia: chronic lymphocytic leukaemia (chronic lymphoblastic leukaemia, CLL) – most often affecting people over age 55; chronic myeloid leukaemia (chronic myelogenous leukaemia, CML) – affects mainly adults; acute lymphocytic leukaemia (acute lymphoblastic leukaemia, ALL) – the most co… More >>
Product Description
Professor Juanne Clarke has spent her career as a medical sociologist, exploring the public health system and the personal health systems of individuals. One of her books examined how women with breast cancer deal with diagnosis, prognosis, and treatment. Then her 17-year old daughter Lauren was diagnosed with leukemia, and the theories and paradigms of academe gave way to the real-life struggle of a mother and her daughter for healing and for the best medical treatment possible. Finding Strength details two years in the lives of these two women, from early symptoms and denial, through diagnosis and two years of treatment, to a clean bill of health. Each chapter first describes the events of a particular time … More >>
Product Description
Charles Brenton Huggins won the Nobel prize in 1966 for his extensive work in cancer research. He has spent fifty years at the laboratory bench exploring the nature of this disease in an attempt to understand and control it. In this volume, based almost exclusively on experiments conducted over the past twenty years at the University of Chicago, is both the record of Huggins’s own research and, in Huggins’s words, “a do-it-yourself guide for cancer research workers.” Written simply and clearly so that the experiments can be easily reproduced, the book presents Huggins’s experiments in the induction of breast cancer and leukemia in rodents. It also describes the methods he discovered to prevent cancer and to cur… More >>
Product Description
This volume covers all important aspects of drug resistance in leukemia and lymphoma. General mechanisms of resistance are discussed, including the drug resistance related proteins, MRP (multi drug resistance protein) and LRP (lung resistance protein), and the role of glutathione and glutathione-S-transferases, as well as drug-specific mechanisms of resistance, apoptosis and its regulators and modulation of drug resistance…. More >>
Product Description
In the last decade many studies have been performed in the field of drug resistance. This book reviews the current status and indicates future directions of such studies. Both laboratory scientists and clinicians have recognized the importance of drug resistance for the clinical outcome of patients with leukemia and lymphoma. New in vitro cell culture assays have been developed and the in vitro drug resistance measured with these assays has been shown to correlate with both short and long-term clinical response to chemotherapy. This book is, therefore, an essential guide for researchers and clinicians.
Drug Resistance in Leukemia and Lymphoma contains material presented at the 2nd International Symposium in … More >>
Product Description
The last ten years have seen the publication of a vast amount of data regarding cellular resistance to drugs in cancer cells. Recent studies have demonstrated that drug resistance assays appear to be predictive of clinical response and suggest that clinicians should now be considering the potential applications of these assays in the treatment of patients with hematological neoplasms. This collection of papers from the International Symposium on the Clinical Value of Drug Resistance Assays in Leukemia and Lymphoma, Amsterdam, 1992, provides a state-of-the-art discussion on drug resistance assays and their role in the design and individualization of treatment protocols…. More >>
|
|
